Neurocognitive Disorders

Latest

Methylphenidate & CBT Benefits TBI Patients with Cognitive Problems

Methylphenidate & CBT Benefits TBI Patients with Cognitive Problems

These preliminary findings suggest that combined treatment with MAAT and methylphenidate can improve attention, episodic and working memory, and executive functioning following traumatic brain injury.

Exploring Possible Causes of Decreasing Dementia Rates In the US

Exploring Possible Causes of Decreasing Dementia Rates In the US

Better management of cardiovascular risk factors and higher levels of education may have contributed to this improvement.

Midlife Hypertension and Late-life Neurocognitive Status

Midlife Hypertension and Late-life Neurocognitive Status

The American Heart Association issues a scientific statement on the possible link between chronic arterial hypertension and cognitive impairment.

Inhaled Levodopa for 'Off' Periods in Parkinson Disease

Inhaled Levodopa for 'Off' Periods in Parkinson Disease

Levodopa pill can wear off, but a powdered version can help patients during off periods.

Gender-dependent Differences in Alzheimer Disease Diagnosis

Gender-dependent Differences in Alzheimer Disease Diagnosis

In 2016, an estimated 5.4 million US adults have Alzheimer disease.

T2D and Cognition: Role of Ghrelin System

T2D and Cognition: Role of Ghrelin System

Serum ghrelin levels may serve as a biomarker of executive function in patients with type 2 diabetes.

Investigating Superagers' Neuroanatomy, Memory Abilities

Investigating Superagers' Neuroanatomy, Memory Abilities

Most aging humans will develop some degree of decline in cognitive capacity.

Statins May Be Protective Against Parkinson's in Diabetes

Statins May Be Protective Against Parkinson's in Diabetes

The study suggests that statins may serve a greater purpose beyond control of lipids and cardiovascular events.

Active Music Therapy May Be Beneficial in Parkinson's

Active Music Therapy May Be Beneficial in Parkinson's

Researchers saw a beneficial effect in tests examining frontal lobe function and improvement in memory.

Dopaminergic Control of Striatal Cholinergic Interneurons May Cause Antipsychotic-Associated Parkinsonism

Dopaminergic Control of Striatal Cholinergic Interneurons May Cause Antipsychotic-Associated Parkinsonism

Research examines the underlying mechanisms for the disabling adverse effects associated with antipsychotic medications.

Latest Videos

Sign Up for Free e-newsletters